$ACMR

McKechnie Mark sold $4.3M of ACMR

McKechnie Mark (See Remarks) sold 55,199 shares of ACM Research, Inc. (ACMR) at an average of $77.27 ($76.34–$77.89, $4.26M total) across 3 trades on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · McKechnie Mark
Published Aug 22, 2026, 1:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 1:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Bearish
medium confidence
Mentioned
$ACMR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRBearishLow
01

Why it matters

The insider sale reduces insider ownership, which some traders view as a bearish signal.

02

Market read

Insider sell of $4.3M may influence short-term price action for ACMR.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 5/10Timing: filed after market close on 2026-08-21

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$ACMRBearishMedium confidence
Context

Officer Mark McKechnie sold 55,199 shares for $4.3M via a 10b5-1 plan, reducing his stake to 900 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

The sale size ($4.3M) is material for a small-cap and executed under a pre-arranged plan, suggesting a neutral to slightly bearish signal.

Market effects

Minimal impact on the broader semiconductor equipment sector.

Limited to U.S. investors tracking insider activity.

Low

Counterpoint

The 10b5-1 plan may have been pre-scheduled, not reflecting current sentiment.

Key entities

  • ACM Research, Inc.

    Semiconductor equipment manufacturer.

  • Mark McKechnie

    Company officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.